The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can
aid in objectively diagnosing patients and providing individualized treatment …

With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …

BackgroundEvidence on risk factors for postpartum depression (PPD) are fragmented and
inconsistent. AimsTo assess the strength and credibility of evidence on risk factors of PPD …

Schizophrenia is a serious mental illness that requires continuous and effective long-term
management to reduce symptoms, improve quality of life, and prevent relapse. Oral …

Background Antipsychotic doses for relapse prevention in patients with first-episode
schizophrenia that have the highest likelihood of success are unknown. We aimed to study …

Introduction Maintenance antipsychotic treatment improves multiple outcomes in people with
schizophrenia. These benefits are challenged by medication nonadherence, which is a …

Background Schizophrenia is a complex neuropsychiatric disorder for which several
etiopathological theories have been proposed, one of the prominent ones being immune …

Background and hypothesis Speech is a promising marker to aid diagnosis of schizophrenia-
spectrum disorders, as it reflects symptoms like thought disorder and negative symptoms …

Background: Factors related to medication adherence in patients with schizophrenia have
always been key to the treatment and rehabilitation of these patients. However, the treatment …

Introduction Treatment resistant schizophrenia (TRS), the lack of response to at least two
antipsychotics administered at adequate dose and duration, epitomizes in psychiatry one of …